Asiatic acid and maslinic acid protected heart via anti-glycative and anti-coagulatory activities in diabetic mice

Yi Chih Hung, Hui Ting Yang, Mei Chin Yin

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The cardiac protective effects of asiatic acid (AA) and maslinic acid (MA) in diabetic mice were examined. These triterpenoids at 0.1 or 0.2% of the diet were supplied to diabetic mice for 12 weeks. The AA or MA treatments decreased plasma glucose and HbA1c levels, and creatine phosphokinase and lactate dehydrogenase activities in diabetic mice (p < 0.05). AA or MA intake increased the amount deposited in the heart which retained the cardiac glutathione content and reduced the production of reactive oxygen species, Nε-(carboxymethyl)-lysine, pentosidine, methylglyoxal, interleukin-6, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 in the hearts of diabetic mice (p < 0.05). AA or MA intake lowered plasma von Willebrand factor and fibrinogen levels, and factor VII activity (p < 0.05), also AA or MA intake maintained circulating antithrombin-III and protein C activities (p < 0.05). AA or MA treatments down-regulated cardiac expression of NADPH oxidase, aldose reductase, nuclear factor kappa B (NF-κB) p65 and p-p38; as well as reserving glyoxalase 1 expression (p < 0.05). These two compounds at only 0.2% lowered cardiac expression of NF-κB p50, p-ERK1/2 and the receptor of the advanced glycation endproduct (p < 0.05). These findings support the conclusion that the supplement of these triterpenoids could protect the heart under diabetic conditions via attenuating glycative injury and coagulatory disorders.

Original languageEnglish
Pages (from-to)2967-2974
Number of pages8
JournalFood and Function
Volume6
Issue number9
DOIs
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

heart
acids
mice
NF-kappa B
Antithrombin Proteins
Pyruvaldehyde
Aldehyde Reductase
Factor VII
acid treatment
triterpenoids
Antithrombin III
Chemokine CCL2
NADPH Oxidase
von Willebrand Factor
Creatine Kinase
Protein C
L-Lactate Dehydrogenase
pentosidine
Fibrinogen
Glutathione

ASJC Scopus subject areas

  • Food Science

Cite this

Asiatic acid and maslinic acid protected heart via anti-glycative and anti-coagulatory activities in diabetic mice. / Hung, Yi Chih; Yang, Hui Ting; Yin, Mei Chin.

In: Food and Function, Vol. 6, No. 9, 01.01.2015, p. 2967-2974.

Research output: Contribution to journalArticle

@article{052403ac2cd242438a200936116f5a13,
title = "Asiatic acid and maslinic acid protected heart via anti-glycative and anti-coagulatory activities in diabetic mice",
abstract = "The cardiac protective effects of asiatic acid (AA) and maslinic acid (MA) in diabetic mice were examined. These triterpenoids at 0.1 or 0.2{\%} of the diet were supplied to diabetic mice for 12 weeks. The AA or MA treatments decreased plasma glucose and HbA1c levels, and creatine phosphokinase and lactate dehydrogenase activities in diabetic mice (p < 0.05). AA or MA intake increased the amount deposited in the heart which retained the cardiac glutathione content and reduced the production of reactive oxygen species, Nε-(carboxymethyl)-lysine, pentosidine, methylglyoxal, interleukin-6, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 in the hearts of diabetic mice (p < 0.05). AA or MA intake lowered plasma von Willebrand factor and fibrinogen levels, and factor VII activity (p < 0.05), also AA or MA intake maintained circulating antithrombin-III and protein C activities (p < 0.05). AA or MA treatments down-regulated cardiac expression of NADPH oxidase, aldose reductase, nuclear factor kappa B (NF-κB) p65 and p-p38; as well as reserving glyoxalase 1 expression (p < 0.05). These two compounds at only 0.2{\%} lowered cardiac expression of NF-κB p50, p-ERK1/2 and the receptor of the advanced glycation endproduct (p < 0.05). These findings support the conclusion that the supplement of these triterpenoids could protect the heart under diabetic conditions via attenuating glycative injury and coagulatory disorders.",
author = "Hung, {Yi Chih} and Yang, {Hui Ting} and Yin, {Mei Chin}",
year = "2015",
month = "1",
day = "1",
doi = "10.1039/c5fo00549c",
language = "English",
volume = "6",
pages = "2967--2974",
journal = "Food and Function",
issn = "2042-6496",
publisher = "Royal Society of Chemistry",
number = "9",

}

TY - JOUR

T1 - Asiatic acid and maslinic acid protected heart via anti-glycative and anti-coagulatory activities in diabetic mice

AU - Hung, Yi Chih

AU - Yang, Hui Ting

AU - Yin, Mei Chin

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The cardiac protective effects of asiatic acid (AA) and maslinic acid (MA) in diabetic mice were examined. These triterpenoids at 0.1 or 0.2% of the diet were supplied to diabetic mice for 12 weeks. The AA or MA treatments decreased plasma glucose and HbA1c levels, and creatine phosphokinase and lactate dehydrogenase activities in diabetic mice (p < 0.05). AA or MA intake increased the amount deposited in the heart which retained the cardiac glutathione content and reduced the production of reactive oxygen species, Nε-(carboxymethyl)-lysine, pentosidine, methylglyoxal, interleukin-6, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 in the hearts of diabetic mice (p < 0.05). AA or MA intake lowered plasma von Willebrand factor and fibrinogen levels, and factor VII activity (p < 0.05), also AA or MA intake maintained circulating antithrombin-III and protein C activities (p < 0.05). AA or MA treatments down-regulated cardiac expression of NADPH oxidase, aldose reductase, nuclear factor kappa B (NF-κB) p65 and p-p38; as well as reserving glyoxalase 1 expression (p < 0.05). These two compounds at only 0.2% lowered cardiac expression of NF-κB p50, p-ERK1/2 and the receptor of the advanced glycation endproduct (p < 0.05). These findings support the conclusion that the supplement of these triterpenoids could protect the heart under diabetic conditions via attenuating glycative injury and coagulatory disorders.

AB - The cardiac protective effects of asiatic acid (AA) and maslinic acid (MA) in diabetic mice were examined. These triterpenoids at 0.1 or 0.2% of the diet were supplied to diabetic mice for 12 weeks. The AA or MA treatments decreased plasma glucose and HbA1c levels, and creatine phosphokinase and lactate dehydrogenase activities in diabetic mice (p < 0.05). AA or MA intake increased the amount deposited in the heart which retained the cardiac glutathione content and reduced the production of reactive oxygen species, Nε-(carboxymethyl)-lysine, pentosidine, methylglyoxal, interleukin-6, tumor necrosis factor-alpha and monocyte chemoattractant protein-1 in the hearts of diabetic mice (p < 0.05). AA or MA intake lowered plasma von Willebrand factor and fibrinogen levels, and factor VII activity (p < 0.05), also AA or MA intake maintained circulating antithrombin-III and protein C activities (p < 0.05). AA or MA treatments down-regulated cardiac expression of NADPH oxidase, aldose reductase, nuclear factor kappa B (NF-κB) p65 and p-p38; as well as reserving glyoxalase 1 expression (p < 0.05). These two compounds at only 0.2% lowered cardiac expression of NF-κB p50, p-ERK1/2 and the receptor of the advanced glycation endproduct (p < 0.05). These findings support the conclusion that the supplement of these triterpenoids could protect the heart under diabetic conditions via attenuating glycative injury and coagulatory disorders.

UR - http://www.scopus.com/inward/record.url?scp=84940831944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940831944&partnerID=8YFLogxK

U2 - 10.1039/c5fo00549c

DO - 10.1039/c5fo00549c

M3 - Article

VL - 6

SP - 2967

EP - 2974

JO - Food and Function

JF - Food and Function

SN - 2042-6496

IS - 9

ER -